2016 Applications Are Live!
President’s Challenge – Apply Now
Deans’ Health and Life Sciences Challenge – Apply Now
Deans’ Cultural Entrepreneurship Challenge – Apply Now
2016 Health and Life Sciences Topic Areas
Diagnostics and Data Analytics
Diagnostic tests that are fast, accurate, low cost and accessible are crucial to the timely and effective care of patients. So too are tools to collect, manage, and analyze data. We are interested in technologies that impact how we identify and manage individual and population health.
Devices and Materials
Medical devices have the potential to improve clinical outcomes and/or a patient’s quality of life. We are seeking ideas that combine engineering, science, medicine and attractive business models to develop novel materials or innovative devices that will play a role in improving health delivery and care.
Health IT and Wearables
Wearable and other related personal measurement technologies have the potential to redefine how individuals and caregivers understand and manage health. We are calling for solutions that either generate or interpret data streams to improve health outcomes.
Personalized Treatment and Prevention
The ability to contextualize a person’s profile, from genetic to behavioral, to tailor medical decisions, preventative care, treatment plans and/or products for individual patients is redefining healthcare delivery. We are looking for effective solutions and innovation technologies that allow for health providers, individuals and families to make more informed decisions on how to treat and care for patients.
You can find more information on the Deans’ Challenges here.
The 2015 Health and Life Science finalists were:
Blue Therapeutics is developing painkillers that are more potent than morphine at relieving pain but are not addictive.
Canary provides ultrasensitive protein pregnancy detection for point-of-care and home testing.
FLEEThealth is creating an interoperable application programming interface (API) for medical data to bring health care into the Internet age.
LuminOva aims to increase in vitro fertilization success rates by monitoring the viability of embryos.
Poly6 Biotechnologies develops synthetic, bioresorbable polymers for drug delivery, anti-adhesions and tissue regeneration.
To read the Harvard Gazette story about Finalists in this and other Deans’ Challenges, click here.